Universe Pharmaceuticals (UPC) Total Current Liabilities (2020 - 2025)

Universe Pharmaceuticals has disclosed Total Current Liabilities across 6 years of filings, most recently posting $13.2 billion for Q3 2025.

• Total Current Liabilities for Q3 2025 came in at $13.2 billion, down 35.15% year-over-year; the trailing twelve-month figure through Sep 2025 was $13.2 billion (down 35.15% YoY), and the FY2025 annual result was $13.2 billion, down 35.15% from the prior year.
• Total Current Liabilities came in at $13.2 billion for Q3 2025 at Universe Pharmaceuticals, down from $20.3 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $20.3 billion in Q3 2024 to a low of $10.2 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $17.2 million (2023), against an average of $4.2 billion.
• Across the five-year window, Total Current Liabilities tumbled 100.0% in 2021 and soared 147584.19% in 2024, its largest moves.
• Universe Pharmaceuticals' Total Current Liabilities stood at $11.2 million in 2021, then rose by 16.83% to $13.1 million in 2022, then grew by 5.01% to $13.8 million in 2023, then jumped by 147584.19% to $20.3 billion in 2024, then sank by 35.15% to $13.2 billion in 2025.
• The last three Total Current Liabilities figures came in at $13.2 billion (Q3 2025), $20.3 billion (Q3 2024), and $20.6 million (Q1 2024), per Business Quant data.